Government ContextGovernment Context
DocumentsDocuments by topicDocuments by agencyPricingLog inCreate account
Nonrulemaking

Requests that the FDA declare that the drug product, Lenalidomide Oral Solution 5 mg/mL is suitable for consideration in an Abbreviated New Drug Application.

🏛 Food and Drug Administration (FDA)FDA-2026-P-7177
Documents
6
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 6Supporting & Related Material 4Other 2